CTDSPL and chronic myelogenous leukemia, BCR-ABL1 positive: It promotes proliferation and inhibits apoptosis in AML and chronic myeloid leukemia (CML) cells by targeting CTDSPL and TRIB2 (Khalaj et al., 2017; Zhang et al., 2013).